Meihao Medical Group (HKG:1947) expects a net loss of between 29.4 million yuan and 35.9 million yuan for the year 2024, wider than the 13.6 million loss a year prior, a Thursday filing with the Hong Kong bourse said.
The medical equipment manufacturer attributed the anticipated loss mainly to a significant decline in its sales price leading to a lower profit margin from implant dentistry services, intense competition, lower consumer spending, and higher staff costs.
Price (HKD): $0.34, Change: $-0.020, Percent Change: -5.56%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.